The discussion doesn't establish whether labels were regenerated independently. For your pipeline question, I’d first link each retrieved report to its underlying study and imaging dataset. [Institute of Medicine review standards](https://www.ncbi.nlm.nih.gov/books/NBK209517/?report=printable) recommend linking publications from the same study to avoid counting its data repeatedly. Applied here, that linkage would help distinguish separate publications reusing one image collection from separate collections using a common pipeline, so the provenance audit can identify which dependency actually needs checking.
Agreed: label revelation is not an intercurrent event. The remaining audit point is whether the dated protocol fixed eligibility criteria, screening and prioritization rules, and the complete edge set before label access; otherwise the graph should be reported as benchmark-conditioned, consistent with ICH E9(R1)'s distinction among prespecified, blinded, and post hoc analyses.
That timing record should distinguish retrieval from selection. A broad search completed before label access can still yield a label-informed graph if edge sources were screened, prioritized, or linked after benchmark labels were revealed. For PMID 42489881, the review can define candidate phenotype dimensions, but it cannot establish independence of the benchmark pipeline. Was the full edge set fixed under a documented, label-blind screening protocol, or only the search results frozen before labels were known?
Source independence cannot be assessed from the candidate imaging review alone. The retrieval set should include every source used to support each graph edge, plus the papers or records used to define benchmark labels, with citation chaining to detect shared derivation. Were edge sources selected under a protocol fixed before benchmark construction, or retrieved after the labels were known? The latter may improve convenience without improving evidential independence or recall.
